The first sprayable insecticide made of RNA can target and kill ravenous Colorado potato beetles while sparing most ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

Fintel reports that on October 28, 2025, RBC Capital downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from ...

Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after ...

The University at Albany and Virginia Commonwealth University were awarded a $6.5 million NIH grant to establish a federal ...

Stock futures edged higher on Monday as optimism over a potential US-China trade deal and a widely expected Federal Reserve ...

Cells contain a blueprint in the form of DNA that dictates what they can make.This blueprint is converted into a message, or mRNA, which is then ...

Avidity Biosciences (RNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ...